Icu Medical (ICUI) Stock
Infusion therapy and vascular access device manufacturer. Here's the price, business snapshot, and what's worth knowing about Icu Medical in May 2026.
ICU Medical Inc (ICUI) is a US-based medical device company that designs, manufactures and sells infusion therapy systems, vascular access devices and related consumables for hospitals and clinics. Investors should note that the business model combines durable capital equipment with recurring revenue from single-use disposables, which can support steady cash flows but is exposed to hospital purchasing cycles and reimbursement dynamics. Growth drivers include new product introductions, replacement demand, aftermarket consumables and selective acquisitions, while risks include regulatory approvals, competitive pressure from larger med-tech peers and possible margin volatility. The company operates in a highly regulated sector where quality and compliance are critical. Financial strength, pricing power and a stable installed base are key metrics to watch. This is general educational information, not personal financial advice — values can rise and fall and past performance is not a guide to future returns.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying ICU Medical's stock, with a target price suggesting significant growth potential.
Financial Health
ICU Medical is generating strong revenue and cash flow, with a solid profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Abbott
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
AGILENT TECHNOLOGIES INC
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
ALIGN TECHNOLOGY INC
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Baskets Featuring ICUI
Wearable Tech IP Wars: What Investors Should Know
Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.
Published: August 21, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring consumable revenue
A steady stream of single‑use supplies can support predictable sales, though hospital purchasing cycles and pricing pressure may affect growth.
Regulatory and quality focus
Product approvals and compliance are essential in med‑tech; regulatory outcomes can materially influence performance and costs.
Market position and growth
New product launches and selective acquisitions can expand reach internationally, but competition from larger peers remains a consideration.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
